Total Payments
$12,844
2024 Payments
$4,032
Companies
44
Transactions
493
Medicare Patients
8,529
Medicare Billing
$905,610
Payment Breakdown by Category
Food & Beverage$11,454 (89.2%)
Travel$827.35 (6.4%)
Education$562.77 (4.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,454 | 484 | 89.2% |
| Travel and Lodging | $827.35 | 1 | 6.4% |
| Education | $562.77 | 8 | 4.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| MERZ NORTH AMERICA, INC. | $2,232 | 25 | $0 (2024) |
| Janssen Biotech, Inc. | $1,485 | 56 | $0 (2024) |
| PFIZER INC. | $1,445 | 79 | $0 (2024) |
| ABBVIE INC. | $1,117 | 48 | $0 (2024) |
| Lilly USA, LLC | $1,103 | 62 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $680.14 | 7 | $0 (2024) |
| Galderma Laboratories, L.P. | $630.57 | 27 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $470.60 | 22 | $0 (2024) |
| REVANCE THERAPEUTICS, INC. | $466.59 | 6 | $0 (2024) |
| Dermavant Sciences, Inc. | $406.75 | 26 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,032 | 87 | MERZ NORTH AMERICA, INC. ($1,194) |
| 2023 | $1,741 | 68 | Merz North America, Inc. ($396.98) |
| 2022 | $1,544 | 66 | Merz North America, Inc. ($344.35) |
| 2021 | $793.44 | 31 | Galderma Laboratories, L.P. ($242.35) |
| 2020 | $356.96 | 21 | PFIZER INC. ($112.96) |
| 2019 | $1,896 | 78 | AbbVie, Inc. ($454.59) |
| 2018 | $1,171 | 71 | Lilly USA, LLC ($183.68) |
| 2017 | $1,309 | 71 | Janssen Biotech, Inc. ($259.25) |
All Payment Transactions
493 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: DERMATOLOGY | ||||||
| 12/20/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: DERMATOLOGY | ||||||
| 12/19/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $24.12 | General |
| Category: Dermatology | ||||||
| 12/19/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: DERMATOLOGY | ||||||
| 12/12/2024 | MERZ NORTH AMERICA, INC. | Xeomin (Biological) | Food and Beverage | In-kind items and services | $171.27 | General |
| Category: Dermatology | ||||||
| 12/03/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $29.82 | General |
| Category: Dermatology | ||||||
| 12/03/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $22.47 | General |
| Category: Dermatology | ||||||
| 11/27/2024 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $29.89 | General |
| Category: Inflammation & Immunology | ||||||
| 11/22/2024 | MERZ NORTH AMERICA, INC. | Xeomin | Travel and Lodging | In-kind items and services | $827.35 | General |
| 11/21/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $86.05 | General |
| Category: Dermatology | ||||||
| 11/21/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $28.74 | General |
| Category: Dermatology | ||||||
| 11/20/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $22.11 | General |
| Category: Dermatology | ||||||
| 11/19/2024 | MERZ NORTH AMERICA, INC. | Xeomin (Biological) | Food and Beverage | In-kind items and services | $179.17 | General |
| Category: Dermatology | ||||||
| 11/18/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $30.56 | General |
| Category: Immunology | ||||||
| 11/15/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $44.40 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 11/15/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $20.40 | General |
| Category: Dermatology | ||||||
| 11/15/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 11/14/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: DERMATOLOGY | ||||||
| 11/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: Immunology | ||||||
| 11/08/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $219.12 | General |
| Category: Dermatology | ||||||
| 11/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $32.27 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: Immunology | ||||||
| 11/05/2024 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $25.26 | General |
| Category: Inflammation & Immunology | ||||||
| 10/31/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $160.33 | General |
| Category: Dermatology | ||||||
| 10/31/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $33.89 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 2,630 | 4,560 | $1.4M | $285,428 |
| 2022 | 21 | 2,215 | 3,323 | $984,409 | $225,658 |
| 2021 | 17 | 2,110 | 3,711 | $1.2M | $250,184 |
| 2020 | 16 | 1,574 | 2,713 | $660,080 | $144,339 |
Total Patients
8,529
Total Services
14,307
Medicare Billing
$905,610
Procedure Codes
76
All Medicare Procedures & Services
76 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 620 | 993 | $347,550 | $76,852 | 22.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 451 | 590 | $227,740 | $52,074 | 22.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 183 | 246 | $123,000 | $27,728 | 22.5% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 122 | 167 | $158,650 | $23,908 | 15.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 255 | 338 | $101,400 | $18,203 | 18.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 173 | 173 | $77,850 | $15,346 | 19.7% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 172 | 289 | $57,222 | $13,311 | 23.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 71 | 92 | $59,800 | $9,232 | 15.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 54 | 54 | $35,100 | $7,509 | 21.4% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 36 | 48 | $33,600 | $7,019 | 20.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 177 | 1,061 | $53,050 | $6,531 | 12.3% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 21 | 21 | $26,250 | $5,597 | 21.3% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 52 | 90 | $22,500 | $4,260 | 18.9% |
| 11901 | Injection into skin growth, more than 7 growths | Office | 2023 | 25 | 69 | $20,700 | $4,040 | 19.5% |
| 10040 | Acne surgery | Office | 2023 | 31 | 32 | $13,920 | $3,284 | 23.6% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 21 | 26 | $15,600 | $2,602 | 16.7% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 23 | 23 | $11,224 | $2,418 | 21.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 35 | 38 | $9,500 | $1,681 | 17.7% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 12 | 12 | $12,000 | $1,491 | 12.4% |
| 11401 | Removal of noncancer skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 11 | 11 | $6,600 | $1,415 | 21.4% |
| 11105 | Punch biopsy, each additional skin growth | Office | 2023 | 11 | 14 | $3,206 | $784.77 | 24.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 74 | 173 | $8,650 | $141.64 | 1.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 395 | 478 | $184,076 | $46,253 | 25.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 414 | 524 | $179,624 | $43,199 | 24.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 156 | 216 | $99,975 | $24,612 | 24.6% |
About Dr. Mitchell Mandel, M.D
Dr. Mitchell Mandel, M.D is a Dermatopathology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1710076427.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mitchell Mandel, M.D has received a total of $12,844 in payments from pharmaceutical and medical device companies, with $4,032 received in 2024. These payments were reported across 493 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($11,454).
As a Medicare-enrolled provider, Mandel has provided services to 8,529 Medicare beneficiaries, totaling 14,307 services with total Medicare billing of $905,610. Data is available for 4 years (2020–2023), covering 76 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatopathology
- Other Specialties Dermatology, Clinical & Laboratory Dermatological Immunology
- Location New York, NY
- Active Since 10/12/2006
- Last Updated 12/16/2023
- Taxonomy Code 207ND0900X
- Entity Type Individual
- NPI Number 1710076427
Products in Payments
- EUCRISA (Drug) $1,059
- TALTZ (Drug) $1,021
- TREMFYA (Drug) $968.34
- Zoryve (Drug) $680.14
- Xeomin (Biological) $669.80
- Humira (Biological) $518.03
- DAXXIFY (Drug) $466.59
- VTAMA (Drug) $406.75
- Tremfya (Drug) $396.98
- CIBINQO (Drug) $386.09
- OPZELURA (Drug) $307.43
- SKYRIZI (Biological) $300.70
- COSENTYX (Biological) $295.49
- EPIDUO FORTE (Drug) $229.24
- Otezla (Drug) $220.63
- STELARA (Biological) $210.18
- XEOMIN (Biological) $193.98
- Skyrizi (Biological) $179.89
- Seysara (Drug) $177.54
- COSENTYX (Drug) $175.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatopathology Doctors in New York
Dr. Alejandro Gru, Md, MD
Dermatopathology — Payments: $249,067
Dermatopathology $249,067
Tatyana Groysman, D.o, D.O
Dermatopathology — Payments: $7,965
Dermatopathology $7,965
Dr. Travis Hollmann, M.d., Ph.d, M.D., PH.D
Dermatopathology — Payments: $4,436
Dermatopathology $4,436
Robert Phelps, Md, MD
Dermatopathology — Payments: $3,397
Dermatopathology $3,397
Seth Wilentz, Md, MD
Dermatopathology — Payments: $923.07
Dermatopathology $923.07
Elen Blochin, Md, MD
Dermatopathology — Payments: $703.73
Dermatopathology $703.73